Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies

Повышение терапевтической эффективности наночастиц при лечении рака с использованием универсальных стратегий таргетирования
Edouard Collins Nice, Canhua Huang, Tingting Zhang, Na Xie, Zhao Huang, Siyuan Qin, Li Zhou, Jiayan Shi, Hailong Tian, Zhisen Shen
2022-09-12

active targeting ligandscancer therapyenhanced permeability and retention effectstimuli-responsive nanoplatformstargeted nanoparticle drug delivery
Poor targeting of therapeutics leading to severe adverse effects on normal tissues is considered one of the obstacles in cancer therapy. To help overcome this, nanoscale drug delivery systems have provided an alternative avenue for improving the therapeutic potential of various agents and bioactive molecules through the enhanced permeability and retention (EPR) effect. Nanosystems with cancer-targeted ligands can achieve effective delivery to the tumor cells utilizing cell surface-specific receptors, the tumor vasculature and antigens with high accuracy and affinity. Additionally, stimuli-responsive nanoplatforms have also been considered as a promising and effective targeting strategy against tumors, as these nanoplatforms maintain their stealth feature under normal conditions, but upon homing in on cancerous lesions or their microenvironment, are responsive and release their cargoes. In this review, we comprehensively summarize the field of active targeting drug delivery systems and a number of stimuli-responsive release studies in the context of emerging nanoplatform development, and also discuss how this knowledge can contribute to further improvements in clinical practice.
1
Cancer-targeted ligands enable nanosystems to deliver therapeutics selectively through tumor-cell receptors, tumor vasculature, and tumor-associated antigens.
2
Nanoparticle-based drug delivery systems can improve therapeutic potential by exploiting the enhanced permeability and retention effect in tumors.
3
Stimuli-responsive nanoplatforms remain stealthy under normal conditions but release their cargo after encountering tumors or their microenvironment.
4
Targeted nanoplatforms are presented as a strategy to reduce therapeutic exposure and severe adverse effects in normal tissues.
5
The review synthesizes active-targeting delivery systems and stimuli-responsive release strategies to guide development of improved clinical nanotherapies.

nanoparticle-based drug delivery systems for cancer treatment

targeted delivery strategies and stimuli-responsive cargo release for enhancing therapeutic efficacy while reducing adverse effects on normal tissues

Publication Details
Publication Date
2022-09-12
Journal
Publisher
ISSN
Cited by
430
Access Type
Author Information
Authors
Edouard Collins Nice
Canhua Huang
Tingting Zhang
Na Xie
Zhao Huang
Siyuan Qin
Li Zhou
Jiayan Shi
Hailong Tian
Zhisen Shen
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%